1:35pm ET
Health and Healthcare
Regeneron and Sanofi Plan to Appeal Amgen Patent Verdict
Regeneron Pharmaceuticals saw its shares halted on Wednesday afternoon after a jury ruled in favor of Amgen on a cholesterol drug patent.
Companies
Regeneron Pharmaceuticals Inc
$827.72
▼ $15.75 (−1.87%) today
Markets closed · 10:36pm ET
REGN Coverage
Page 1112:05pm ET
Health and Healthcare
Regeneron Scores Win in Late-Stage Rheumatoid Arthritis Trial
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) scored a win in a late-stage trial for the treatment of rheumatoid arthritis (RA). The company, in conjunction with Sanofi, announced that a Phase 3 monotherapy study…
Chris Lange 5:15pm ET
Health and Healthcare
Why Citi Sees Huge Upside in 4 Top Biotechs Now
Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four of the largest names within the biotech space.
9:05am ET
Health and Healthcare
Regeneron Falls on Missed Earnings
Regeneron Pharmaceuticals reported disappointing fourth-quarter financial results before the markets opened on Tuesday.
Chris Lange 12:40pm ET
Health and Healthcare
Regeneron Downgrade Highlights at Least Some Risks
Regeneron Pharmaceuticals seems to have held up rather well against an analyst downgrade on Wednesday.
Jon C. Ogg 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald’s, Merck, Newmont, Sprint and More
Wednesday's top analyst calls include Apple, AT&T, DuPont, Fitbit, Huntington Bancshares, McDonald's, Merck, Newmont Mining and Sprint.
10:05am ET
Health and Healthcare
UBS Loves These 3 Top Biotech Stock Leaders Into Q3 Earnings
Given the massive beat-down in the sector, if these companies surpass earnings expectations, the upside could be sizable.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AIG, Facebook, Gilead, Google, Regeneron, Twitter, Valeant, Vertex and More
Friday’s top analyst upgrades, downgrades and initiations include AIG, Facebook, Gilead Sciences, Google, Regeneron Pharmaceuticals, Twitter, Valeant Pharmaceuticals and Vertex Pharmaceuticals.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Amgen, Dow, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum and Many More
Tuesday’s top analyst upgrades, downgrades and initiations include Amgen, Dow Chemical, Fitbit, Office Depot, SanDisk, Wells Fargo and Yum! Brands.
6:40am ET
Investing
4 Stocks to Sell Now, Until the Fed Acts
Monday was historic. But these types of movements are not one off. They usually come in clusters.
8:20am ET
Health and Healthcare
3 Large Biotech Stocks to Buy Despite Higher Interest Rates Coming
Merrill Lynch has looked at large cap biotech leaders and how interest rate increases may play a part in stock performance.
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Cheniere, First Solar, Hilton, NOV, Disney and Many More
Wednesday's top analyst upgrades, downgrades and initiations include Apple, Cheniere Energy, First Solar, Hilton Worldwide, National Oilwell Varco and Disney.
8:26am ET
Investing
Top Analyst Upgrades and Downgrades: Baidu, BlackBerry, GM, PayPal, Teva, Yelp and Many More
Jon OggStocks were indicated higher on Tuesday morning after 5 days in a row of selling. Yet again we see the trend of investors finding a reason to buy every stock market…
11:53am ET
Health and Healthcare
Have Analysts Fully Priced in Praluent to Regeneron?
ThinkstockRegeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced last Friday that the U.S. Food and Drug Administration (FDA) approved Praluent (alirocumab) Injection. Praluent is indicated as an adjunct to diet…
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, Exxon, LifeLock, Microsoft, PayPal, Chipotle and More
Wednesday's top analyst upgrades, downgrades and initiations include Apple, Exxon Mobil, LifeLock, Microsoft, PayPal and Chipotle Mexican Grill.